Literature DB >> 22864648

Impact of 22q11.2 deletion on the postoperative course of children after cardiac surgery.

Rachel McDonald1, Andrew Dodgen, Sunali Goyal, Jeffrey M Gossett, Takeshi Shinkawa, Santosh C Uppu, Carlos Blanco, Xiomara Garcia, Adnan T Bhutta, Michiaki Imamura, Punkaj Gupta.   

Abstract

The primary objective of this study was to describe the impact of 22q11.2 deletion (del22q11) on the clinical characteristics, postoperative course, and short-term outcomes of children undergoing surgery for congenital heart disease. The charts of all children ages 1 day-18 years who received cardiac surgery for interrupted aortic arch (IAA), tetralogy of Fallot (TOF), or truncus arteriosus (TA) repair from 1 January 2001 to 31 December 2011 were retrospectively reviewed. The patients were divided into two groups: the 22q11 group including children with del22q11 undergoing surgery for TOF, IAA, or TA and the non-22q11 or control group including children with no chromosomal or genetic abnormality undergoing surgery for TOF, IAA, or TA. Demographic information, cardiac diagnoses, noncardiac abnormalities, preoperative factors, intraoperative details, surgical procedures performed, postoperative complications, and in-hospital deaths were collected. The outcome data collected included days of inotrope use, need for dialysis, length of mechanical ventilation, intensive care unit (ICU) length of stay (LOS), hospital LOS, and mortality. The study enrolled 173 patients: 65 patients in the 22q11 group and 108 patients in the control group. Of the 65 patients in the 22q11 group, 36 (55 %) underwent repair for TOF, 13 (20 %) for IAA, and 16 (25 %) for TA. The two groups did not differ in terms of age or weight. The preexisting conditions were similar in the two groups. Unplanned noncardiac operations were more common in the children with del22q11, but delayed chest closure was similar in the two groups. The incidence of postoperative noncardiac complications such as reintubation, vocal cord paralysis, and diaphragmatic paralysis was similar in the two groups. However, increasing numbers of patients in del22q11 group needed dialysis in one form or the other during the immediate postoperative stay. The incidence of fungal infection and wound infection was higher in the del22q11 group than in the control group. Duration of mechanical ventilation, ICU LOS, and hospital LOS were similar in the two groups, except in certain subgroups. Mortality did not differ significantly between the two groups. In conclusion, children with del22q11 have a higher risk of postoperative complications after cardiac surgery, with no difference in length of mechanical ventilation, ICU LOS, hospital LOS, or mortality. However, short-term outcomes may differ in certain subgroups.

Entities:  

Mesh:

Year:  2012        PMID: 22864648     DOI: 10.1007/s00246-012-0454-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  21 in total

1.  Influence of chromosome 22q11.2 microdeletion on surgical outcome after treatment of tetralogy of fallot with pulmonary atresia.

Authors:  Adriano Carotti; Bruno Marino; Roberto M Di Donato
Journal:  J Thorac Cardiovasc Surg       Date:  2003-11       Impact factor: 5.209

2.  Impact of DEL22q11, trisomy 21, and other genetic syndromes on surgical outcome of conotruncal heart defects.

Authors:  Guido Michielon; Bruno Marino; Gianluca Oricchio; Maria Cristina Digilio; Fiore Iorio; Sergio Filippelli; Silvia Placidi; Roberto M Di Donato
Journal:  J Thorac Cardiovasc Surg       Date:  2009-05-23       Impact factor: 5.209

3.  Velocardiofacial syndrome: incidence of immune cytopenias.

Authors:  S G Duke; W F McGuirt; T Jewett; M B Fasano
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-09

Review 4.  Congenital heart disease and genetic syndromes: specific correlation between cardiac phenotype and genotype.

Authors:  B Marino; M C Digilio
Journal:  Cardiovasc Pathol       Date:  2000 Nov-Dec       Impact factor: 2.185

5.  Determinants of outcome after surgical treatment of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries.

Authors:  Adriano Carotti; Sonia B Albanese; Sergio Filippelli; Lucilla Ravà; Paolo Guccione; Giacomo Pongiglione; Roberto M Di Donato
Journal:  J Thorac Cardiovasc Surg       Date:  2010-09-17       Impact factor: 5.209

Review 6.  Velocardiofacial (Shprintzen) syndrome: an important syndrome for the dysmorphologist to recognise.

Authors:  A H Lipson; D Yuille; M Angel; P G Thompson; J G Vandervoord; E J Beckenham
Journal:  J Med Genet       Date:  1991-09       Impact factor: 6.318

7.  Do neonates with genetic abnormalities have an increased morbidity and mortality following cardiac surgery?

Authors:  Janet M Simsic; Karlene Coleman; Kevin O Maher; Angel Cuadrado; Paul M Kirshbom
Journal:  Congenit Heart Dis       Date:  2009 May-Jun       Impact factor: 2.007

Review 8.  Cardiac defects and results of cardiac surgery in 22q11.2 deletion syndrome.

Authors:  Adriano Carotti; Maria Cristina Digilio; Gerardo Piacentini; Claudia Saffirio; Roberto M Di Donato; Bruno Marino
Journal:  Dev Disabil Res Rev       Date:  2008

9.  Cardiovascular anomalies in DiGeorge syndrome and importance of neural crest as a possible pathogenetic factor.

Authors:  L H Van Mierop; L M Kutsche
Journal:  Am J Cardiol       Date:  1986-07-01       Impact factor: 2.778

10.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.

Authors:  A K Ryan; J A Goodship; D I Wilson; N Philip; A Levy; H Seidel; S Schuffenhauer; H Oechsler; B Belohradsky; M Prieur; A Aurias; F L Raymond; J Clayton-Smith; E Hatchwell; C McKeown; F A Beemer; B Dallapiccola; G Novelli; J A Hurst; J Ignatius; A J Green; R M Winter; L Brueton; K Brøndum-Nielsen; P J Scambler
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

View more
  12 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

2.  The Impact of 22q11.2 Microdeletion on Cardiac Surgery Postoperative Outcome.

Authors:  Goran Cuturilo; Danijela Drakulic; Ida Jovanovic; Slobodan Ilic; Jasna Kalanj; Irena Vulicevic; Misela Raus; Dejan Skoric; Marija Mijovic; Biljana Medjo; Snezana Rsovac; Milena Stevanovic
Journal:  Pediatr Cardiol       Date:  2017-09-22       Impact factor: 1.655

3.  22q11.2 Deletion Status and Perioperative Outcomes for Tetralogy of Fallot with Pulmonary Atresia and Multiple Aortopulmonary Collateral Vessels.

Authors:  Laura Mercer-Rosa; Okan U Elci; Nelangi M Pinto; Ronn E Tanel; Elizabeth Goldmuntz
Journal:  Pediatr Cardiol       Date:  2018-03-08       Impact factor: 1.655

Review 4.  Congenital heart diseases and cardiovascular abnormalities in 22q11.2 deletion syndrome: From well-established knowledge to new frontiers.

Authors:  Marta Unolt; Paolo Versacci; Silvia Anaclerio; Caterina Lambiase; Giulio Calcagni; Matteo Trezzi; Adriano Carotti; Terrence Blaine Crowley; Elaine H Zackai; Elizabeth Goldmuntz; James William Gaynor; Maria Cristina Digilio; Donna M McDonald-McGinn; Bruno Marino
Journal:  Am J Med Genet A       Date:  2018-04-16       Impact factor: 2.802

Review 5.  22q11.2 Deletion Syndrome: Impact of Genetics in the Treatment of Conotruncal Heart Defects.

Authors:  Carolina Putotto; Flaminia Pugnaloni; Marta Unolt; Stella Maiolo; Matteo Trezzi; Maria Cristina Digilio; Annapaola Cirillo; Giuseppe Limongelli; Bruno Marino; Giulio Calcagni; Paolo Versacci
Journal:  Children (Basel)       Date:  2022-05-25

6.  Current Practice and Utility of Chromosome Microarray Analysis in Infants Undergoing Cardiac Surgery.

Authors:  Jason R Buckley; Minoo N Kavarana; Shahryar M Chowdhury; Mark A Scheurer
Journal:  Congenit Heart Dis       Date:  2014-12-14       Impact factor: 2.007

7.  Complex Chronic Conditions Among Children Undergoing Cardiac Surgery.

Authors:  Titus Chan; Jane Di Gennaro; Stephanie Burns Wechsler; Susan L Bratton
Journal:  Pediatr Cardiol       Date:  2016-03-31       Impact factor: 1.655

8.  Congenital Heart Disease as a Warning Sign for the Diagnosis of the 22q11.2 Deletion.

Authors:  Marcília S Grassi; Cristina M A Jacob; Leslie D Kulikowski; Antonio C Pastorino; Roberta L Dutra; Nana Miura; Marcelo B Jatene; Stephanie P Pegler; Chong A Kim; Magda Carneiro-Sampaio
Journal:  Arq Bras Cardiol       Date:  2014-10-10       Impact factor: 2.000

9.  Case fatality rate and associated factors in patients with 22q11 microdeletion syndrome: a retrospective cohort study.

Authors:  Gabriela M Repetto; M Luisa Guzmán; Iris Delgado; Hugo Loyola; Mirta Palomares; Guillermo Lay-Son; Cecilia Vial; Felipe Benavides; Karena Espinoza; Patricia Alvarez
Journal:  BMJ Open       Date:  2014-11-06       Impact factor: 2.692

Review 10.  Congenital heart defects in CHARGE: The molecular role of CHD7 and effects on cardiac phenotype and clinical outcomes.

Authors:  Joshua K Meisner; Donna M Martin
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-12-13       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.